Lytix Biopharma AS: Lytix presents encouraging preclinical data in triple negative breast cancer in collaboration with Weill Cornell Medicine

Press/Media

PeriodNov 13 2021

Media coverage

1

Media coverage

  • TitleLytix Biopharma AS: Lytix presents encouraging preclinical data in triple negative breast cancer in collaboration with Weill Cornell Medicine
    Media name/outletImpact Financial News
    Country/TerritoryUnited Kingdom
    Date11/13/21
    PersonsLorenzo Galluzzi
View all 1
View less